Test Price
2,800 AED✅ Home Collection Available
DNAH9 Gene Primary Ciliary Dyskinesia Genetic Test (NGS) in Dubai, UAE
Executive Summary & Core Metrics
The DNAH9 gene NGS test provides definitive molecular confirmation of primary ciliary dyskinesia (PCD) with 99.9% diagnostic sensitivity, validated through ISO-accredited sequencing protocols.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO-Accredited NGS Technology.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection, available daily 8 AM – 11 PM.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance with a DHA-licensed genetic specialist.
- Insurance & Billing: Direct Billing Verification available via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This advanced NGS panel analyzes the entire DNAH9 coding region, detecting copy number variations and deep intronic variants that Sanger sequencing may miss. It is the most comprehensive genetic analysis for primary ciliary dyskinesia, a disorder causing chronic ENT infections, situs inversus, and infertility.
| Feature | Our Test (NGS) | Closest Alternative (Sanger) |
|---|---|---|
| Precision | Covers entire DNAH9 coding region, CNVs, and deep intronic variants | Limited to targeted exons |
| Method | NGS with 1000x read depth | Capillary electrophoresis |
| Speed | 3 – 4 Weeks | 6 – 8 Weeks |
Physician Insight & Safety Protocols
"As a DHA-licensed Consultant in Medical Genetics, I correlate the molecular findings of the DNAH9 gene with clinical phenotypes such as chronic sino-pulmonary disease, laterality defects, and fertility issues. Full informed consent, including pre- and post-test genetic counseling, is mandatory under Federal Decree-Law No. 4 of 2016 on Medical Liability. Discontinue prescribed therapy only under the direct guidance of your referring physician."
⚠️ Clinical Safety Advisory
Do not discontinue prescribed respiratory or cardiac medications without consulting your physician. This genetic test provides diagnostic clarity but does not replace acute clinical management.
Safety Exclusion & Emergency Red Flags
- Exclusion Criteria: Active systemic infection, severe anemia (Hb < 7 g/dL), inability to provide informed consent (minors require parental consent per Federal Decree-Law No. 4 of 2016), known coagulopathy unless cleared by attending physician.
- ER Red Flags: Persistent oozing, expanding hematoma, signs of hypovolemic shock, or dyspnea after phlebotomy – seek immediate emergency care.
- Pre-Test Preparation: Provide a detailed clinical history of recurrent ENT infections, situs inversus, or unexplained infertility. A three-generation pedigree is strongly recommended.
Patient FAQ & Clinical Guidance
1. What is the DNAH9 gene primary ciliary dyskinesia test?
This advanced NGS analyzes the entire DNAH9 gene for mutations causing primary ciliary dyskinesia, ensuring accurate diagnosis to guide targeted ENT and respiratory management.
2. Why choose NGS technology over traditional sequencing?
NGS provides comprehensive gene coverage and higher sensitivity, detecting rare mutations and copy number variations that Sanger sequencing might miss.
3. What is the turnaround time and sample requirement?
Results are delivered within 3 to 4 weeks from a simple blood draw, buccal swab, or existing DNA sample. VIP Mobile Phlebotomy is available for home collection.
4. Is genetic counseling included with this test?
Yes, post-test telephonic clinical guidance with a DHA-licensed genetic specialist is included to help you understand your results and their implications for family planning.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE strictly complies with the UAE's premier data protection and healthcare informatics regulations:
- Data Privacy: Fully compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL), ensuring your genomic data is encrypted, anonymized, and never shared without explicit consent.
- Health Data Governance: Adherence to Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, securing all digital health records and telemedicine interactions.
- Laboratory Accreditation: Our Dubai Healthcare City facility (DHA License 1143) operates under ISO 9001:2015 standards, guaranteeing international quality benchmarks in genetic diagnostics.
Clinical & Logistical Metadata
| Test Name | DNAH9 Gene Primary Ciliary Dyskinesia Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 – 4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood, Extracted DNA, or Buccal Swab |
| Methodology Used | Next Generation Sequencing (NGS), 1000x read depth |
| ICD-10-CM Code | Q34.8, Z15.89, Z14.8 |
| LOINC Code | 81247-7 |
| DHA Facility License & Address | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DHA License No: 1143 |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians